The efficacy of antihypertensive drug therapy is undisputed, but observational studies show that few patients reach a target blood pressure o140/90 mm Hg. However, there is limited data on the drug prescribing patterns and their effectiveness in real practice. This retrospective observational survey of electronic patient records extracted data from 24 Swedish primary healthcare centres, with a combined registered population of 330 000 subjects. We included all patients X30 years with a recorded diagnosis of hypertension who consulted the centres in 2005 or 2006 (n ¼ 21 167). Main outcome measures were systolic and diastolic blood pressures, and prescribed antihypertensive drug classes. Only 27% had a blood pressure o140/ 90 mm Hg. The number of prescribed drugs increased with age, except among the oldest (X90 years). Only 29% of patients given monotherapy had a blood pressure o140/90 mm Hg. Women more often received diuretics (52 vs 42%), and less often angiotensinconverting enzyme inhibitors (22 vs 33%) and calcium channel blockers (26 vs 31%) than men. b-Blockers and diuretics were the most common drug classes prescribed, independent of comorbidity. In conclusion, one out of four primary care patients with hypertension reach target blood pressure. More frequent use of drug combinations may improve blood pressure control.
Introduction
Hypertension is common, with an estimated prevalence at 27% in the adult Swedish population 1 and similar rates in other countries. 2, 3 Indeed, hypertension is the major global cause of premature death. 4 Thus, it is important to improve the recognition and treatment of hypertensive patients.
Large trials have clearly demonstrated that blood pressure reduction by antihypertensive drug therapy substantially reduces the risk of non-fatal and fatal cardiovascular events. 5, 6 As only a minority of hypertensive patients reaches target blood pressure 2, 7 it is important to study blood pressure levels and drug prescribing in clinical practice to identify areas for improvement. Some studies on prescribing patterns and blood pressure values have been conducted in primary health care, but most studies are based on small populations [8] [9] [10] or using selfreported data from questionnaires. 11, 12 Recent studies have established that antihypertensive treatment is effective also in the very old patients. 13 Compared with male patients, hypertension in women has attained little interest, but current evidence suggests that women benefit from antihypertensive treatment similar to men. 14 Also, it has been suggested that hypertensive patients with high cardiovascular risk because of concomitant cardiovascular disease or diabetes should attain lower target blood pressure, [15] [16] [17] although more recent recommendations caution against too low blood pressure targets because of lack of firm clinical evidence, and the possible risk of myocardial ischemia in patients with advanced coronary artery disease. 18 However, these aspects of the management of hypertensive patients in primary health care have not been well studied. To address these important issues, we performed a large retrospective observational study in Swedish primary health care, with over 21 000 hypertensive subjects.
Materials and methods

Patients
Primary health care is the basis of the Swedish health-care system. This observational study was undertaken in 24 primary health-care centres in the south-western part of Stockholm County, Sweden. The centres represented a mixed urban area with a population of 330 000 subjects in 2006. All centres were group practices of varying size from 5 to 20 general practitioners, and are part of a quality collaboration administered by the local Drug and Therapeutics Committee since 1992. This collaboration has agreed on how diagnoses and quality parameters should be registered in the electronic medical records.
We included all patients 30 years or older with a diagnosis of hypertension, according to the International Classification of Diseases (ICD-10; codes I10-15) who had visited any of the 24 primary health-care centres between 1 January 2005 and 31 December 2006. The crude prevalence of diagnosed hypertension was calculated by dividing the number of patients with hypertension with the population in the catchment area during the study period.
This study was performed according to institutional guidelines and was approved of by the appropriate ethics committee.
Data management
Data were extracted from the electronic medical records (ProfDoc II, Profdoc AB, Uppsala, Sweden) using RAVE software (Medtrac AB, Stockholm, Sweden). 19 The RAVE software extracts data from the medical record database, making it possible to link recorded data, such as diagnosis, laboratory findings and text. In 85% of all consultations performed in these primary health-care centres in 2006, a diagnosis had been registered in the medical record following established standards.
Recorded data included age, gender, comorbidity, last recorded blood pressures and prescribed drugs. Cardiovascular comorbidity, henceforth comorbidity, (with corresponding ICD-10 codes) was defined as atrial fibrillation (I48), congestive heart failure (I50), diabetes mellitus (E10-11), ischaemic heart disease (I20-25) or previous stroke/transient ischaemic attack (I60-69), diagnosed since 2001. Patients without any of the prespecified cardiovascular comorbidities were considered to have no cardiovascular comorbidity. Risk factors such as cholesterol and smoking habits were also recorded.
Prescribed antihypertensive drug classes analysed (with corresponding anatomic therapeutic chemical classification system codes) were angiotensinconverting enzyme inhibitors (ACEIs; C09A and C09B), angiotensin II receptor blockers (ARBs; C09C and C09D), b-blockers (C07), calcium channel blockers (C08) and diuretics (C03).
Patient outcome was assessed as the proportion of patients with the last recorded blood pressure value o140/90 mm Hg during the study period (for patients with diabetes o130/80 mm Hg), according to current guidelines. 15, 17 We also evaluated the proportion of patients p140/90 mm Hg, as these values were suggested by the county quality collaboration recommendation at that time.
Statistical methods
Data are presented as mean values ± s.d. or 95% confidence intervals (CI), where appropriate. Statistical analyses were performed using Student's t-test for comparison of means, and two-sample tests of proportions for relative frequencies. Direct standardization was used to obtain point estimates of means and proportions adjusted for age and/or comorbidity. The association between age and changes in blood pressure was assessed using linear regression with sex and age-strata in 5-year bands as independent variables. Statistical significance was considered with a two-sided probability (P) o0.05. Stata version 10.1 (College Station, TX, USA) was used for the analyses.
Results
Patient characteristics
A total of 197 000 subjects 30 years of age or older had a consultation at the primary health-care centres during the study period, and 21 167 patients were identified with a recorded diagnosis of hypertension (Table 1) . Thus, 11% of subjects with a visit during the 2-year period had a recorded diagnosis of hypertension. The most common cardiovascular comorbidity was diabetes, representing approximately one-third. Comorbidity was more common in men than in women (crude difference 8.2%, 95% CI 6.8-9.5, Po0.001). These gender differences increased further when adjusted for age (age-adjusted proportions: women 35.5% (95% CI 34.6-36.6); men 47.0% (95% CI 46.0-48.0)). More than two-thirds of all patients had elevated cholesterol levels, and onethird (of patients wherein information on smoking habits was available) were smokers.
Blood pressures
Most patients (87%) with a diagnosis of hypertension had a blood pressure value reported in the medical records. Systolic blood pressure increased with age, and more in women than in men ( Figure 1 ).
The increase in systolic blood pressure per 5-years increase in age were 1.4 (95% CI 1.3-1.6; Po0.001) and 0.6 mm Hg (95% CI 0.4-0.7; Po0.001) in women and men, respectively. In a combined model with sex as co-variate, and adjusted for age, female sex was associated with an increase in systolic blood pressure of 1.2 mm Hg (95% CI 0.7-1.8; Po0.001) relative to males.
Although significant gender differences in systolic and diastolic blood pressure were observed in specific age-strata (Figure 1 ), the apparent difference in mean systolic and diastolic blood pressure Attained for 8384 patients, 4579 women and 3805 men, in which information on smoking was provided. If assumed that patients with no information on smoking habits in medical records were non-smokers, the proportions of female and male smokers would be 13.7 and 15.9%, respectively, with a crude difference of À2.2% (95% CI À3.2 to À1.2%).
Subjects with no diagnosis of atrial fibrillation, ischaemic heart disease, congestive heart failure, cerebrovascular disease or diabetes mellitus were considered to have no cardiovascular disease.
Antihypertensive treatment and control M Qvarnström et al (148 ± 20 vs 146 ± 18 mm Hg, Po0.001, and 83 ± 10 vs 84 ± 11 mm Hg, Po0.001 in women and men, respectively) did not remain significant when adjusting for age. Target blood pressure was more commonly achieved for diastolic than systolic blood pressure. Thus, target diastolic blood pressure was achieved in 71 and 66% of women and men, respectively (Po0.001), and target systolic pressure in 29 and 32%, respectively (Po0.001). A blood pressure o140/90 mm Hg was reported in 27% of all patients (26 and 29% in women and men, respectively, Po0.001). Corresponding values for patients with and without diabetes mellitus were 30 and 27%, respectively. A blood pressure o130/80 mm Hg was observed in 7% of patients with diabetes mellitus, and in 6% of those without diabetes.
Digit preference to the closest 5 or 10 mm Hg value appeared common, as illustrated for systolic blood pressure in Figure 2 . Accordingly, if target blood pressure was defined as p140/90 mm Hg, a considerably greater proportion reached target (45%).
The number of patients in the total population on 0, 1, 2, 3, 4 or 5 antihypertensive drugs were 2010 (11%), 6189 (33%), 6238 (34%), 3132 (17%), 878 (5%) and 55 (o1%), respectively. The proportion reaching blood pressure targets remained low, independent of the number of drugs, (that is, 23, 29, 28, 26, 23 and 20%, respectively).
Drug treatment in relation to age
Most patients with hypertension (89% of women and 88% of men) were prescribed antihypertensive drugs. The proportion treated with drugs increased with age, except in the oldest age group (Figure 3) . b-Blockers were the most commonly prescribed antihypertensive drugs for patients below the age of 70. In older patients, diuretics were most commonly used. ACEI and ARB were less often used with increasing age.
Drug treatment in relation to gender
Diuretics were more common in women, while ACEI and calcium channel blocker were more common in men (Figure 4 ). Women were more often prescribed one or two drugs than men (34 vs 32%, P ¼ 0.021, and 34 vs 32%, Po0.001), while combinations of three and four drugs were more common in men (16 vs 17%, P ¼ 0.006 and 4 vs 6%, Po 0.001). These significant differences remained also when adjusted for age and comorbidity.
Drug treatment for patients with cardiovascular comorbidity Drug treatment displayed different patterns in patients with cardiovascular comorbidity (Table 2) . Only two-thirds of patients with hypertension and diabetes mellitus or congestive heart failure received an ACEI or ARB, while one-third of hypertensive patients with heart failure and one-fourth with ischaemic heart disease did not have a b-blocker.
Discussion
Several important features contribute to the strength of this study. First, it is a large observational study comprising more than 21 000 patients. Second, it included all patients diagnosed with hypertension in primary health care in the region, regardless of socioeconomic status, and with no bias in the selection in patients or physicians because of any voluntary participation. Third, we used data extracted from electronic records, not self-reported questionnaires, including information on prescribed drugs. Of note, we find other important cardiovascular risk factors common in hypertensive patients, such as high cholesterol levels and smoking. We confirm findings from Sweden 8,9,20 and elsewhere 21, 22 that few patients reach their blood pressure targets despite being treated with antihypertensive drugs.
There are several potential explanations to the observation that target blood pressure is reached only in few hypertensive subjects. Drugs may be prescribed with an inappropriate dosing, or inadequate drug combinations may be used. Patient adherence to prescribed therapy may be low because of lack of motivation among prescribers or patients. Caregivers may consider side effects with antihypertensive drugs a problem, or that available evidence to treat the very old insufficient. Organisational issues in primary health care and insufficient systematic follow-up could also contribute. Thus, there is considerable room for improvement of blood pressure control in patients with hypertension in primary health care. Indeed, few patients with one or two drug classes were well controlled. This suggests that many patients with inadequate control were not offered additional drug therapy. Our results imply that patients may often be in need of an additional antihypertensive drug class.
We found that b-blockers were the most commonly prescribed drug class to patients below the age of 70 years, with or without specific comorbidity. A common view is that the major drug classes ACEI, ARB, calcium channel blockers, b-blockers and diuretics appear to reduce cardiovascular events to a similar extent. 5, 6, 15, 18, 23 Others propose that b-blockers may provide less benefit on outcome. 24, 25 Our results most likely reflect that b-blockers have previously been recommended as first-line therapy in Sweden, and the slow implementation of new findings and recommendations. 26 This study population provides us with a rather large number of very old patients. These patients received less antihypertensive treatment, in agreement with findings by others. 27 More recently, however, evidence in favour drug therapy also in the very old has been presented. 13 Some 13% of our study population were 80 years or older and without a diagnosis of congestive heart failure, that is, comparable to the subjects included in HYVET, Abbreviations: ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; CCB, calcium channel blocker. Subjects with no diagnosis of atrial fibrillation, ischaemic heart disease, congestive heart failure, cerebrovascular disease or diabetes mellitus were considered to have no cardiovascular disease.
Antihypertensive treatment and control M Qvarnström et al and 10% were not below the target blood pressure of that study (o150/80 mm Hg). With this new evidence (presented after our study was carried out) in favour of treating the very old, 13 it is important to recognize this large group of very old hypertensive patients, and to educate patients and health professionals in the potential benefit of antihypertensive drug treatment.
We found that women were better controlled than men at a younger age, but less well controlled when older, and women were more often subject to one or two drugs, while men were given combination therapy with three or more drugs more often. This and other studies 8, 28 show that women were prescribed diuretics more often than men, while ACEI and calcium channel blockers were less often given to women. This could, at least in part, be explained by concomitant conditions, in which some antihypertensive drug classes may have beneficial effects beyond that of blood pressure reduction, or by side effects related to gender. 29 It is generally recognized that patients with diabetes should be treated to lower blood pressure targets, and antihypertensive treatment should include an ACEI or an ARB. 15, 17, 18 Accordingly, 69% had ACEI or an ARB, but few reached a blood pressure below 130/80 mm Hg. This is in agreement with other findings in the voluntary Swedish National Diabetic Register 30 and elsewhere. 31 Furthermore, high-risk patients often need to be given two or more antihypertensive drugs in order to reduce blood pressure to target. 32, 33 We found that 71% did not have a target blood pressure when given monotherapy. Thus, there is a need to improve the treatment of patients with high cardiovascular risk, such as those with diabetes mellitus.
Our results suggest that terminal digit preference to the nearest 5 mm Hg value may be common (see Figure 2 ), in agreement with previous observations, 34, 35 Accordingly, the proportion of patients within target blood pressure was increased if the value 140/90 mm Hg was included in the blood pressure target definition. However, current recommendations state that blood pressure readings should be done to the nearest even number, and target blood pressure should be below 140/ 90 mm Hg. 15, 18 Although the number of patients not well controlled remains unacceptable high, whichever definition for target blood pressure is applied, our findings also show the need for education and training on how to correctly measure and report blood pressure.
This study has certain limitations. Although we included all hypertensive patients within primary health care in a mixed urban region of more than 330 000 people, and the results are in agreement with findings by others in Sweden, 8, 9, 20 it cannot be taken for certain that our findings can be generalized to other populations. We used medical record data to analyse blood pressures in relation to prescribed drugs. Some values represented newly diagnosed patients and we cannot conclude to what extent target blood pressures represented actual blood pressures obtained on definite treatment. Also, drugs may be prescribed according to guidelines, but the patient may not purchase the prescription. 36 We did not have the opportunity to investigate whether appropriate dosages of the medications were used. Moreover, we cannot ascertain that these drug combinations actually were prescribed as such, and not prescriptions changed during the year. Finally, we did not have 24-h ambulatory blood pressure measurements available, which may reflect true blood pressure levels better than office blood pressure values. However, office blood pressure remains the most common way to assess hypertensive patients in primary health care.
In conclusion, just one out of four patients with diagnosed hypertension reach target blood pressure. Several patients with inadequate control were on one or two drug classes only, suggesting that titration of antihypertensive drug treatment may improve blood pressure control. This could have substantial effects on cardiovascular outcome.
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